Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Research

Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial

Nicholas J.G. Pimlott, Janet E. Hux, Lynn M. Wilson, Meldon Kahan, Cindy Li and Walter W. Rosser
CMAJ April 01, 2003 168 (7) 835-839;
Nicholas J.G. Pimlott
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet E. Hux
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lynn M. Wilson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meldon Kahan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cindy Li
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter W. Rosser
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading
Submit a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
References
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Minimum 7 characters.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'. Minimum 12 characters.
Your organization, institution's or residential address.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

  • Prevention of Problematic or Rational Prescribing
    John Grabowski PhD
    Posted on: 01 April 2003
  • Posted on: (1 April 2003)
    Page navigation anchor for Prevention of Problematic or Rational Prescribing
    Prevention of Problematic or Rational Prescribing
    • John Grabowski PhD, Professor/Scientist

    To the Editor and Authors Pimlott et al.:

    “The lack of diagnostic data on the prescription claims in our study made it impossible to evaluate the appropriateness of an individual prescription.” This statement is a key and major flaw to the entire study. The prescribing may or may not have been rational or optimal. Efforts to ‘change prescribing practices' without reference to the diagnosis of the patient seems a...

    Show More

    To the Editor and Authors Pimlott et al.:

    “The lack of diagnostic data on the prescription claims in our study made it impossible to evaluate the appropriateness of an individual prescription.” This statement is a key and major flaw to the entire study. The prescribing may or may not have been rational or optimal. Efforts to ‘change prescribing practices' without reference to the diagnosis of the patient seems anathema to sensible practice or research.

    Benzodiazepines have beneficial effects and problematic side effects. To the extent the physicians were prescribing with attention to both there is little reason to change the patterns. However, interventions that are inattentive to the final consequence are unreasonable regardless of the population. As such they are reminders of the endless ‘war on drugs’ that permeates US prescribing practices for opioids or benzodiazepines. Do you not recall the US congressional hearings on the 'horrors of Valium' several decades ago? The only consequence was a shift to newer benzodiazepines which may or may not have had clinical advantage and about which much less was known.

    Again, prevention of problematic effects is desirable. Prevention of rational prescribing is not.

    Sincerely,

    John Grabowski PhD Professor, Psychiatry and Behavioral Sciences Director, Substance Abuse Research Center University of Texas Health Science Center-Houston

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

CMAJ
Vol. 168, Issue 7
1 Apr 2003
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial
Nicholas J.G. Pimlott, Janet E. Hux, Lynn M. Wilson, Meldon Kahan, Cindy Li, Walter W. Rosser
CMAJ Apr 2003, 168 (7) 835-839;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial
Nicholas J.G. Pimlott, Janet E. Hux, Lynn M. Wilson, Meldon Kahan, Cindy Li, Walter W. Rosser
CMAJ Apr 2003, 168 (7) 835-839;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Interpretation
    • Appendix 1
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights of this issue
  • PubMed
  • Google Scholar

Cited By...

  • Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trial
  • The knowledge-to-action cycle: identifying the gaps
  • Google Scholar

More in this TOC Section

  • Acute presentations of eating disorders among adolescents and adults before and during the COVID-19 pandemic in Ontario, Canada
  • Self-harm among youth during the first 28 months of the COVID-19 pandemic in Ontario, Canada: a population-based study
  • Emergency department visits and hospital admissions for suicidal ideation, self-poisoning and self-harm among adolescents in Canada during the COVID-19 pandemic
Show more Research

Similar Articles

Collections

  • Topics
    • Cognitive impairment (not dementia)
    • Drugs: psychotherapeutic
    • Pharmacology & toxicology

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire